- content
Skeptic critique of 'ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local':
The central weakness is causal ordering. The evidence bundle contains useful mechanistic and biomarker anchors, but most items are search-derived or inherited from a gap debate and therefore do not yet prove that ubiquitylation-dependent turnover is upstream of neuronal injury in the relevant disease context.
Key weaknesses:
- causal direction requires longitudinal perturbation
- evidence_validation_score is still unset, so citations need claim-level validation
A decisive test needs cell-type-aware longitudinal sampling, perturbation in the predicted direction, and a negative-control pathway to rule out a generic stress response. Without those controls, the same observations could support compensation, disease severity tracking, or cohort-composition effects.
- evidence_cited
["four_round_gap_debate [four_round_gap_debate]", "TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]", "Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]", "Neurotrophins and neurodegeneration. [12787319]"]
- argument
Skeptic critique of 'ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local':
The central weakness is causal ordering. The evidence bundle contains useful mechanistic and biomarker anchors, but most items are search-derived or inherited from a gap debate and therefore do not yet prove that ubiquitylation-dependent turnover is upstream of neuronal injury in the relevant disease context.
Key weaknesses:
- causal direction requires longitudinal perturbation
- evidence_validation_score is still unset, so citations need claim-level validation
A decisive test needs cell-type-aware longitudinal sampling, perturbation in the predicted direction, and a negative-control pathway to rule out a generic stress response. Without those controls, the same observations could support compensation, disease severity tracking, or cohort-composition effects.
- evidence
["four_round_gap_debate [four_round_gap_debate]", "TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]", "Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]", "Neurotrophins and neurodegeneration. [12787319]"]